![20190922_164320](https://user-images.githubusercontent.com/22411298/71449590-c51eac00-2775-11ea-844f-b0a18ab220c9.jpg)
## Atanu Bhattacharjee,Ph.D (Statistics)
Assistant Professor Biostatistics
Centre for Cancer Epidemiology, Tata Memorial Centre, India

## Welcome to GitHub Pages
You can use the [editor on GitHub](https://github.com/atanustat/biostat/edit/master/README.md) to maintain and preview the content for your website in Markdown files.

Whenever you commit to this repository, GitHub Pages will run [Jekyll](https://jekyllrb.com/) to rebuild the pages in your site, from the content in your Markdown files.

### Markdown

Markdown is a lightweight and easy-to-use syntax for styling your writing. It includes conventions for

```markdown
Syntax highlighted code block

# Header 1
## Header 2
### Header 3

- Bulleted
- List

1. Numbered
2. List

**Bold** and _Italic_ and `Code` text

[Link](url) and ![Image](src)
```

For more details see [GitHub Flavored Markdown](https://guides.github.com/features/mastering-markdown/).


### Jekyll Themes

Your Pages site will use the layout and styles from the Jekyll theme you have selected in your [repository settings](https://github.com/atanustat/biostat/settings). The name of this theme is saved in the Jekyll `_config.yml` configuration file.


### Teaching

### Research

### Publication
1. Amit Joshi, Sameer Shrirangwar, Vanita Noronha, Nilesh Sable, Archi Agarwal, Palak Popat, Atanu Bhattacharjee, Kumar Prabhash.
 A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer.South Asian J
Cancer 2020;9:23-6.
2. Thiagarajan S, Dhar H, Bhattacharjee A, Fatehi KS, Shah SB, Chaukar D, Nair D, Deshmukh A, Prabhash K, Joshi A, Patil V, Noronha V, Laskar SG, Cruz AKD.Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis.Oral Oncol. 2019 Nov 15;100:104455. doi: 10.1016/j.oraloncology.2019.104455.

### Biostatistics Tutorial
1. Introduction to Biostatistics
[1546938553M1.pdf](https://github.com/atanustat/biostatonco/files/4000779/1546938553M1.pdf)
2. Survival Analysis
[Survival Analysis.pdf](https://github.com/atanustat/biostatonco/files/4000798/Survival.Analysis.pdf)
3. Parametric survival analysis
[parametric survival analysis.pdf](https://github.com/atanustat/biostatonco/files/4000800/parametric.survival.analysis.pdf)
4. Acturial estimator with R
[Acturial estimator with R.pdf](https://github.com/atanustat/biostatonco/files/4000801/Acturial.estimator.with.R.pdf)
5. Kaplan Meier Estimators-I
[Kaplan Meier Estimators-I.pdf](https://github.com/atanustat/biostatonco/files/4000802/Kaplan.Meier.Estimators-I.pdf)
6. Kaplan Meier Estimators-II
[Uploading Kaplan Meier Estimators-Ii.pdf…]()
7. Nelson aalen estimator
[nelson aalen estimator.pdf](https://github.com/atanustat/biostatonco/files/4001281/nelson.aalen.estimator.pdf)
8. Equality of survival
[equality of survival function.pdf](https://github.com/atanustat/biostatonco/files/4001282/equality.of.survival.function.pdf)
9. Mantel Haenszel Estimator
[Mantel-Haenszl Estimators.pdf](https://github.com/atanustat/biostatonco/files/4001284/Mantel-Haenszl.Estimators.pdf)
10. Cox PH Model
[Cox PH model.pdf](https://github.com/atanustat/biostatonco/files/4001285/Cox.PH.model.pdf)

11. Estimation and Inference for Cox’s [Estimation and Inference for Cox’s.pdf](https://github.com/atanustat/biostatonco/files/4001298/Estimation.and.Inference.for.Cox.s.pdf)
12. Diagnostics for Cox’s PH model [Diagnostics for Cox’s PH model.pdf](https://github.com/atanustat/biostatonco/files/4001299/Diagnostics.for.Cox.s.PH.model.pdf)
13. The Accelerated Failure Time [The Accelerated Failure Time.pdf](https://github.com/atanustat/biostatonco/files/4001300/The.Accelerated.Failure.Time.pdf)
14. Competing Risks Model [Competing Risks Model.pdf](https://github.com/atanustat/biostatonco/files/4001301/Competing.Risks.Model.pdf)
15. Clinical Trials [Clinical Trials.pdf](https://github.com/atanustat/biostatonco/files/4001302/Clinical.Trials.pdf)
16. Sample size determination
[sample size determination.pdf](https://github.com/atanustat/biostatonco/files/4001312/sample.size.determination.pdf)
17. Random Allocation
[random allocation.pdf](https://github.com/atanustat/biostatonco/files/4001314/random.allocation.pdf)
18. Sequential Clinical Trial-I
[sequential clinical trial.pdf](https://github.com/atanustat/biostatonco/files/4001315/sequential.clinical.trial.pdf)
19. Sequential Clinical Trial-II
[sequential clinical trial II.pdf](https://github.com/atanustat/biostatonco/files/4001316/sequential.clinical.trial.II.pdf)
20. Sequential Clinical Trial-III
[sequential clinical trial III.pdf](https://github.com/atanustat/biostatonco/files/4001318/sequential.clinical.trial.III.pdf)
21. Randomize play the winder rule
[Randomize play the winder rule.pdf](https://github.com/atanustat/biostatonco/files/4001329/Randomize.play.the.winder.rule.pdf)
22. The Play the Winnder Rule [The Play the Winnder Rule.pdf](https://github.com/atanustat/biostatonco/files/4001331/The.Play.the.Winnder.Rule.pdf)
23. Crossover Trial[Crossover trial.pdf](https://github.com/atanustat/biostatonco/files/4001332/Crossover.trial.pdf)
24. Introduction to Epidemiology[Introduction to Epidemiology.pdf](https://github.com/atanustat/biostatonco/files/4001333/Introduction.to.Epidemiology.pdf)
25. Disease Frequency[Disease Frequency-I.pdf](https://github.com/atanustat/biostatonco/files/4001335/Disease.Frequency-I.pdf)
26. Disease Frequency-II[Disease Frequency-II.pdf](https://github.com/atanustat/biostatonco/files/4001354/Disease.Frequency-II.pdf)
27. Disease Frequency-III[Disease Frequency-III.pdf](https://github.com/atanustat/biostatonco/files/4001358/Disease.Frequency-III.pdf)
28. Observational Study[Observational Study.pdf](https://github.com/atanustat/biostatonco/files/4001360/Observational.Study.pdf)
29. Analystical Study[Analytical Study.pdf](https://github.com/atanustat/biostatonco/files/4001353/Analytical.Study.pdf)
30. Case Control Study[Case Control Study.pdf](https://github.com/atanustat/biostatonco/files/4001352/Case.Control.Study.pdf)
31. Cohort Study-I [Cohort Study -I.pdf](https://github.com/atanustat/biostatonco/files/4001350/Cohort.Study.-I.pdf)
32. Cohort Study-II [Cohort Study-II.pdf](https://github.com/atanustat/biostatonco/files/4001349/Cohort.Study-II.pdf)
33.  Case Control Study -I[case Control Study -I.pdf](https://github.com/atanustat/biostatonco/files/4001346/case.Control.Study.-I.pdf)
34.  Case Control Study -II[Case Control Study II.pdf](https://github.com/atanustat/biostatonco/files/4001343/Case.Control.Study.II.pdf)
35. Confounding[confounding.pdf](https://github.com/atanustat/biostatonco/files/4001342/confounding.pdf)
36. Stratified Analysis[Stratified Analysis.pdf](https://github.com/atanustat/biostatonco/files/4001340/Stratified.Analysis.pdf)
37. Matched Analysis-I[Matched Analysis-I.pdf](https://github.com/atanustat/biostatonco/files/4001337/Matched.Analysis-I.pdf)
38.  Matched Analysis-I[Mathced Analysis-II.pdf](https://github.com/atanustat/biostatonco/files/4001336/Mathced.Analysis-II.pdf)



 
### Contact
abhattacharjee@actrec.gov.in/atanustat@gmail.com   

Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai,India
